Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Allergy Treatment Market Outlook

The global allergy treatment market size attained a value of USD 21.62 billion in 2023 driven by rising demand for Immunotherapy and Anti-Allergy Drugs. The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 to attain a value of USD 38.11 billion by 2032.

Global Allergy Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Cases of Asthma and the Growing Risk of Allergies to Bolster the Growth of the Allergy Treatment Industry

The increasing demand for medical treatments to control asthma is anticipated to aid the market growth in the forecast period. The growing prevalence of asthma among children, geriatrics, and adults owing to the rising pollution levels is contributing to the demand for anti-allergy drugs and immunotherapy. Reckless attitude towards asthma or a lack of knowledge about allergy can lead to airway remodelling, which is a brutal condition. The increasing awareness about the various treatment options available to treat these conditions is likely to bolster the growth of the global allergy treatment industry.

North America Accounts for a Significant Share in the Market

The growing concerns about the need to counter allergies owing to the rising geriatric population are likely to be a major factor driving the allergy treatment industry growth in the region. In addition, the increasing healthcare expenditure and the development of clinics and hospitals in the region are significantly contributing to the market expansion. Furthermore, the market is expected to be aided by the availability of skilled medical professionals who specialise in asthma and eye allergy treatments in countries like the United States and Canada.

Allergy Treatment: Market Segmentation

Allergy treatment is defined as the process of treating an allergy using medicines or allergy shots, or by assisting an individual to avoid a particular substance to prevent further reactions. Allergy treatment may include options like antihistamines and avoiding allergens.

Global Allergy Treatment Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on type, the market is segmented into:

  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Others

On the basis of treatment, the market is divided into:

  • Anti-Allergy Drugs
  • Immunotherapy

Among these, while the anti-allergy drugs segment is further divided into antihistamines, corticosteroids, decongestants, and other drugs, the immunotherapy segment is further categorised into sub-cutaneous immunotherapy (SCIT) and sub-lingual immunotherapy (SLIT) based on type.

The regional markets for allergy treatment include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Allergy Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Demand for Immunotherapy and Anti-Allergy Drugs to Boost the Growth of the Allergy Treatment Industry

The global allergy treatment industry is driven by the growing popularity of various anti-allergy drugs such as antihistamines, which are extremely beneficial for treating patients suffering from allergic reactions to pollen or other allergens. Antihistamines are also used to treat other conditions such as stomach problems, cold, and anxiety, among others. Furthermore, the market is anticipated to be augmented by the rising demand for immunotherapy owing to the fact that this type of treatment is ideal for long-term. The demand for immunotherapy is likely to be propelled by the surging cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others.

Key Industry Players in the Global Allergy Treatment Market

The report gives a detailed analysis of the following key players in the global allergy treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • AbbVie Inc.
  • GlaxoSmithKline PLC
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Sanofi S.A.
  • LETI Pharma, S.L.U.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Treatment
  • Route of Administration
  • End User
  • Region
Breakup by Type
  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Others
Breakup by Treatment
  • Anti-Allergy Drugs
  • Immunotherapy
Breakup by Route of Administration
  • Oral
  • Inhalation
  • Intranasal
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • LETI Pharma, S.L.U.
  • GlaxoSmithKline Plc.
  • Zenomed Healthcare Private Limited
  • F. Hoffmann-La Roche AG
  • Cadila Pharmaceuticals
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Akorn, Incorporated
  • Prestige Consumer Healthcare Inc.
  • Astellas Pharma Inc.
  • Eli Lilly and Company
  • Almirall, S.A

Allergy Treatment Market Report Snapshots

Allergy Treatment Market Size

Allergy Treatment Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

Globally, allergy treatment market reached a value of USD 21.62 billion in 2023.

The market is projected to expand at a CAGR of 6.5% from 2024 to 2032, growing to USD 38.11 billion by 2032.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others, growing demand for immunology and anti-allergy drugs, the rising healthcare expenditure in emerging economies, and the growing awareness about the fatality of allergies, among others, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing investments in R&D activities in the field of medicine, along with the technological advancements in the healthcare infrastructure in emerging economies.

Eye allergy, rhinitis, asthma, skin allergy, and food allergies, among others are the major allergy treatment types.

Anti-allergy drugs and immunotherapy are the different kinds of treatments considered within the market report.

The major players in the industry are AbbVie Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Sanofi S.A., and LETI Pharma, S.L.U., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124